TP A multicenter phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2-positive breast cancer (TUTOR) Conference

Ahluwalia, Manmeet Singh, Ozair, Ahmad, Bardhan, Mainak et al. (2024). TP A multicenter phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2-positive breast cancer (TUTOR) . JOURNAL OF CLINICAL ONCOLOGY, 42(16),

cited authors

  • Ahluwalia, Manmeet Singh; Ozair, Ahmad; Bardhan, Mainak; Bellur, Shreyas S; Perche, Dilanis C; Starosciak, Amy K; Leon-Ariza, Daniel S; Khosla, Atulya Aman; Rubens, Muni; Odia, Yazmin; Mehta, Minesh P; Kotecha, Rupesh; McDermott, Michael W; Sandoval-Leon, Ana Cristina; Mahtani, Reshma L; Peereboom, David M

authors

date/time interval

  • May 29, 2024 -

publication date

  • June 1, 2024

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • ELECTR NETWORK

Conference

  • Special Clinical Science Symposia

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

volume

  • 42

issue

  • 16